Product Information
BUSPIRONE HCL 15 MG TABLET is a generic product labeled by Advagen Pharma Ltd., priced at $0.0423 per EA under NDC 72888006501. Its NADAC has been published 197 times since Sep 21, 2022.
Strength
15 mg/1
Manufacturer
Advagen Pharma Ltd.NDC
72888006501
Classification
Generic
Dosage Form
TABLET
Route
ORAL
Last Updated
6/17/2026
Active Ingredients
BUSPIRONE HYDROCHLORIDEApproval Type
Generic (ANDA)
FDA Application
ANDA075521On Market Since
12/29/2020
Price Statistics
The NADAC for BUSPIRONE HCL 15 MG TABLET has been published 197 times since Sep 21, 2022, and over the history we have for it it has declined 14.8%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.0423 per EA |
|---|---|
| All-time high | $0.0535 (Nov 16, 2022) |
| All-time low | $0.0359 (Nov 20, 2024) |
| 52-week high | $0.0485 |
| 52-week low | $0.0423 |
| Median price | $0.0476 |
| Average price | $0.0470 |
| Largest weekly change | -29.4% (Nov 20, 2024) |
| Weeks tracked | 197 |
| Tracking since | Sep 21, 2022 |
Generic Alternatives
The matcher finds 4 NADAC-published products sharing this drug's active ingredient, strength, and dosage form across 4 manufacturers (up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Frequently asked questions
What is the NADAC price of BUSPIRONE HCL 15 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for BUSPIRONE HCL 15 MG TABLET, manufactured by Advagen Pharma Ltd., is $0.0423 per EA (NDC 72888006501), effective Jun 24, 2026.
How has the price of BUSPIRONE HCL 15 MG TABLET changed over time?
Over the history we have for it, the NADAC for BUSPIRONE HCL 15 MG TABLET has declined 14.8%. It has been tracked across 197 weekly CMS publications since Sep 21, 2022.
What are the highest and lowest recorded NADAC prices for BUSPIRONE HCL 15 MG TABLET?
Since Sep 21, 2022, the NADAC for BUSPIRONE HCL 15 MG TABLET has ranged from a low of $0.0359 (Nov 20, 2024) to a high of $0.0535 (Nov 16, 2022), with a median of $0.0476 per EA.
Are there cheaper alternatives to BUSPIRONE HCL 15 MG TABLET?
4 NADAC-published products share the same active ingredient, strength, and dosage form as BUSPIRONE HCL 15 MG TABLET, but none are currently priced below it.
Who manufactures BUSPIRONE HCL 15 MG TABLET?
BUSPIRONE HCL 15 MG TABLET (NDC 72888006501) is labeled by Advagen Pharma Ltd., and CMS classifies it as a generic product.
Related Drugs
Same classification